EJNMMI Radiopharmacy and Chemistry View Homepage


Ontology type: schema:Periodical      Open Access: True


Journal Info

START YEAR

2015

PUBLISHER

Springer International Publishing

LANGUAGE

en

HOMEPAGE

https://ejnmmipharmchem.springeropen.com

Recent publications latest 20 shown

  • 2022-11-05 A practical fully automated radiosynthesis of [18F]Flurpiridaz on the module modular lab-pharmtracer without external purification
  • 2022-11-04 Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [177Lu]Lu-PSMA
  • 2022-10-23 Gamma counting protocols for the accurate quantification of 225Ac and 213Bi without the need for a secular equilibrium between parent and gamma-emitting daughter
  • 2022-10-22 Good practices for 68Ga radiopharmaceutical production
  • 2022-10-06 A closer look at the synthesis of 2-[18F]fluoroethyl tosylate to minimize the formation of volatile side-products
  • 2022-10-01 Highlight selection of radiochemistry and radiopharmacy developments by editorial board
  • 2022-09-27 Quality control of [177Lu]Lu-PSMA preparations using HPLC: effect of sample composition and ligand on recovery
  • 2022-09-06 The determination of the radiochemical purity of Actinium-225 radiopharmaceuticals: a conundrum
  • 2022-09-05 Favorable SSTR subtype selectivity of SiTATE: new momentum for clinical [18F]SiTATE PET
  • 2022-08-26 Cutting edge rare earth radiometals: prospects for cancer theranostics
  • 2022-07-29 Automated synthesis of [68Ga]Ga-FAPI-46 without pre-purification of the generator eluate on three common synthesis modules and two generator types
  • 2022-07-23 Development of new copper-64 labeled rhodamine: a potential PET myocardial perfusion imaging agent
  • 2022-07-19 Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
  • 2022-07-19 Experience with radiopharmacy information system
  • 2022-07-19 Core–shell structured gold nanoparticles as carrier for 166Dy/166Ho in vivo generator
  • 2022-06-25 Fluorination of silyl prosthetic groups by fluorine mediated silyl ether linker cleavage: a concept study with conditions applicable in radiofluorination
  • 2022-06-13 Current status on cyclotron facilities and related infrastructure supporting PET applications in Latin America and the Caribbean
  • 2022-06-13 Synthesis of a 2-nitroimidazole derivative N-(4-[18F]fluorobenzyl)-2-(2-nitro-1H-imidazol-1-yl)-acetamide ([18 F]FBNA) as PET radiotracer for imaging tumor hypoxia
  • 2022-06-06 Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imaging
  • 2022-05-08 Potential PET tracers for imaging of tumor-associated macrophages
  • JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "contentRating": [
          {
            "author": "snip", 
            "ratingValue": "0.9290000200271606", 
            "type": "Rating"
          }, 
          {
            "author": "sjr", 
            "ratingValue": "0.44699999690055847", 
            "type": "Rating"
          }
        ], 
        "description": "

    EJNMMI Radiopharmacy and Chemistry is a peer-reviewed\u00a0open access Journal and publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers.

    Peer review is conducted using Editorial Manager\u00ae, supported by a database of international experts. This database is shared with the journals European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Physics, EJNMMI Research, and the European Journal of Hybrid Imaging.

    ", "editor": [ { "familyName": "Elsinga", "givenName": "Philip", "type": "Person" } ], "id": "sg:journal.1157056", "inLanguage": [ "en" ], "isAccessibleForFree": true, "issn": [ "2365-421X" ], "license": "Fully Open Access", "name": "EJNMMI Radiopharmacy and Chemistry", "productId": [ { "name": "dimensions_id", "type": "PropertyValue", "value": [ "157056" ] }, { "name": "lccn_id", "type": "PropertyValue", "value": [ "2016247781" ] }, { "name": "nlm_unique_id", "type": "PropertyValue", "value": [ "101714628" ] }, { "name": "nsd_ids_id", "type": "PropertyValue", "value": [ "493509" ] }, { "name": "era_ids_id", "type": "PropertyValue", "value": [ "212341" ] } ], "publisher": { "name": "Springer International Publishing", "type": "Organization" }, "publisherImprint": "Springer", "sameAs": [ "https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1157056" ], "sdDataset": "journals", "sdDatePublished": "2022-11-24T21:22", "sdLicense": "https://scigraph.springernature.com/explorer/license/", "sdPublisher": { "name": "Springer Nature - SN SciGraph project", "type": "Organization" }, "sdSource": "s3://com-springernature-scigraph/baseset/20221124/entities/gbq_results/journal/journal_0.jsonl", "startYear": "2015", "type": "Periodical", "url": "https://ejnmmipharmchem.springeropen.com" } ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/journal.1157056'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/journal.1157056'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/journal.1157056'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/journal.1157056'


     

    This table displays all metadata directly associated to this object as RDF triples.

    59 TRIPLES      20 PREDICATES      26 URIs      22 LITERALS      10 BLANK NODES

    Subject Predicate Object
    1 sg:journal.1157056 schema:contentRating N8de7afcc232e45c1a8f80fb67a24c3ab
    2 Nb007b3e60e4f4836bc4645fc07e49fea
    3 schema:description <p><i>EJNMMI Radiopharmacy and Chemistry </i>is a peer-reviewed open access Journal and publishes new research in the field of development of new imaging and radionuclide-based therapeutic agents for application in nuclear medicine and molecular imaging. The journal provides a platform for chemists, pharmacists and basic scientists to present their views and scientific work. In addition, the journal provides insight into novel concepts of imaging or radionuclide-based therapeutic agent applications of relevance for the whole molecular imaging community. The journal reports original research articles, review papers, guidelines on the application of imaging or radionuclide therapy agents, editorials, and letters to the editor. Research articles on novel radiochemistry, new radiopharmaceuticals including their first biological evaluation, molecular imaging agents including optical imaging, MRI, and hybrid probes, are the main focus of the journal. To translate imaging and radionuclide therapy agents to the clinic, legislative issues related to their production and safety can be presented as well in the form of guidelines or position papers.</p><p>Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with the journals <i>European Journal of Nuclear Medicine and Molecular Imaging, EJNMMI Physics,</i> <i>EJNMMI Research, </i>and the<i> European Journal of Hybrid Imaging.</i></p>
    4 schema:editor Nce3844648ca84f9db902167cbeb646d6
    5 schema:inLanguage en
    6 schema:isAccessibleForFree true
    7 schema:issn 2365-421X
    8 schema:license Fully Open Access
    9 schema:name EJNMMI Radiopharmacy and Chemistry
    10 schema:productId N65ae4e641e0e498cab4266b2280281ea
    11 N6ecec03878b843c2bb3a5a192b5485a0
    12 Nce92d0568a634227a7c6a9e7759faf2d
    13 Ndb73125aa44a4c7ab7ce642a3b52cd95
    14 Nfad41247d63b4b9ab7962554b064b8a2
    15 schema:publisher Ne8928140e9bd4221abef1c34b235396f
    16 schema:publisherImprint Springer
    17 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_source_title=jour.1157056
    18 schema:sdDatePublished 2022-11-24T21:22
    19 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    20 schema:sdPublisher N8f1f4b26682f48bbbe54a1bae2d7c038
    21 schema:startYear 2015
    22 schema:url https://ejnmmipharmchem.springeropen.com
    23 sgo:license sg:explorer/license/
    24 sgo:sdDataset journals
    25 rdf:type schema:Periodical
    26 N6490043190c047bc955eed55a8df5d88 rdf:first sjr
    27 rdf:rest rdf:nil
    28 N65ae4e641e0e498cab4266b2280281ea schema:name dimensions_id
    29 schema:value 157056
    30 rdf:type schema:PropertyValue
    31 N6ecec03878b843c2bb3a5a192b5485a0 schema:name era_ids_id
    32 schema:value 212341
    33 rdf:type schema:PropertyValue
    34 N86da3d033b95425ea0a52e37769f4717 rdf:first snip
    35 rdf:rest rdf:nil
    36 N8de7afcc232e45c1a8f80fb67a24c3ab schema:author N6490043190c047bc955eed55a8df5d88
    37 schema:ratingValue 0.44699999690055847
    38 rdf:type schema:Rating
    39 N8f1f4b26682f48bbbe54a1bae2d7c038 schema:name Springer Nature - SN SciGraph project
    40 rdf:type schema:Organization
    41 Naedd20be00f24ff291a96a1af9867bf8 schema:familyName Elsinga
    42 schema:givenName Philip
    43 rdf:type schema:Person
    44 Nb007b3e60e4f4836bc4645fc07e49fea schema:author N86da3d033b95425ea0a52e37769f4717
    45 schema:ratingValue 0.9290000200271606
    46 rdf:type schema:Rating
    47 Nce3844648ca84f9db902167cbeb646d6 rdf:first Naedd20be00f24ff291a96a1af9867bf8
    48 rdf:rest rdf:nil
    49 Nce92d0568a634227a7c6a9e7759faf2d schema:name lccn_id
    50 schema:value 2016247781
    51 rdf:type schema:PropertyValue
    52 Ndb73125aa44a4c7ab7ce642a3b52cd95 schema:name nlm_unique_id
    53 schema:value 101714628
    54 rdf:type schema:PropertyValue
    55 Ne8928140e9bd4221abef1c34b235396f schema:name Springer International Publishing
    56 rdf:type schema:Organization
    57 Nfad41247d63b4b9ab7962554b064b8a2 schema:name nsd_ids_id
    58 schema:value 493509
    59 rdf:type schema:PropertyValue
     




    Preview window. Press ESC to close (or click here)


    ...